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ABSTRACT 
Unlike clozapine, and despite its structural similarities, olanzapine is not usually associated 
with haematological suppression. Nonetheless this case report highlights an incident of 
olanzapine-induced thrombocytopenia and neutropenia in a first-contact patient. We report on 
a 50-year-old male who presented with 7 years of delusions and hallucinations. A diagnosis of 
schizophrenia was made in the absence of any suggestive features of mood disorders, substance 
abuse or organicity, and olanzapine as second-line treatment. Within a week of starting 
treatment he developed biochemical neutropenia and thrombocytopenia without any clinical 
symptoms that resolved after cessation of the offending drug. An organic workup for infective, 
inflammatory, and neoplastic causes was unremarkable. Comparison with other case reports 
and 3 postulated mechanisms are discussed. Despite its comparative rarity, the addition of this 
case report to a growing corpus suggests that clinicians should maintain heightened 
surveillance of patients prescribed olanzapine, to identify any untoward iatrogenic 
haematological abnormalities or immunosuppression. 
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